Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

被引:46
|
作者
Mounsey, Ross B. [1 ]
Teismann, Peter [1 ]
机构
[1] Univ Aberdeen, Inst Med Sci, Coll Life Sci & Med, Sch Med Sci, Aberdeen AB25 2ZD, Scotland
关键词
NADH-UBIQUINONE OXIDOREDUCTASE; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL; LACKING ALPHA-SYNUCLEIN; APOPTOTIC CELL-DEATH; COMPLEX-I DEFICIENCY; COENZYME Q(10); DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; OXIDATIVE DAMAGE; CYTOCHROME-C;
D O I
10.4061/2011/617472
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mitochondria are vitally important organelles involved in an array of functions. The most notable is their prominent role in energy metabolism, where they generate over 90% of our cellular energy in the form of ATP through oxidative phosphorylation. Mitochondria are involved in various other processes including the regulation of calcium homeostasis and stress response. Mitochondrial complex I impairment and subsequent oxidative stress have been identified as modulators of cell death in experimental models of Parkinson's disease (PD). Identification of specific genes which are involved in the rare familial forms of PD has further augmented the understanding and elevated the role mitochondrial dysfunction is thought to have in disease pathogenesis. This paper provides a review of the role mitochondria may play in idiopathic PD through the study of experimental models and how genetic mutations influence mitochondrial activity. Recent attempts at providing neuroprotection by targeting mitochondria are described and their progress assessed.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
    Blagov, Alexander
    Postnov, Anton
    Sukhorukov, Vasily
    Popov, Mikhail
    Uzokov, Jamol
    Orekhov, Alexander
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):
  • [2] Rabs and Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
    Richbourg, Tara E.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 119 - 119
  • [3] Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease
    Ebadi, M
    Sharma, SK
    ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (03) : 319 - 335
  • [4] Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
    Banerjee, Rebecca
    Starkov, Anatoly A.
    Beal, M. Flint
    Thomas, Bobby
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 651 - 663
  • [5] Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
    Sadegh Moradi Vastegani
    Ava Nasrolahi
    Shahab Ghaderi
    Rafie Belali
    Masome Rashno
    Maryam Farzaneh
    Seyed Esmaeil Khoshnam
    Neurochemical Research, 2023, 48 : 2285 - 2308
  • [6] Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies
    Moradi Vastegani, Sadegh
    Nasrolahi, Ava
    Ghaderi, Shahab
    Belali, Rafie
    Rashno, Masome
    Farzaneh, Maryam
    Khoshnam, Seyed Esmaeil
    NEUROCHEMICAL RESEARCH, 2023, 48 (08) : 2285 - 2308
  • [7] Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson's Disease
    Kung, Heng-Chung
    Lin, Kai-Jung
    Kung, Chia-Te
    Lin, Tsu-Kung
    BIOMEDICINES, 2021, 9 (08)
  • [8] Mitochondrial dysfunction in Parkinson's disease
    Fukae, Jiro
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    MITOCHONDRION, 2007, 7 (1-2) : 58 - 62
  • [9] Mitochondrial Dysfunction in Parkinson's Disease
    Keane, P. C.
    Kurzawa, M.
    Blain, P. G.
    Morris, C. M.
    PARKINSONS DISEASE, 2011, 2011
  • [10] Mitochondrial dysfunction and Parkinson's disease
    Wright, Rebecca
    NATURE NEUROSCIENCE, 2022, 25 (01) : 2 - 2